SK Biopharmaceuticals Co., Ltd. (326030.KS)
KRW 103600.0
(-2.54%)
KRW 103600.0
(-2.54%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -419.89 KRW | 76.42% |
| 2022 | -1780.43 KRW | -315.02% |
| 2021 | 828.03 KRW | 124.02% |
| 2020 | -3447.52 KRW | 5.62% |
| 2019 | -3652.99 KRW | -64.62% |
| 2018 | -2219.00 KRW | -13.62% |
| 2017 | -1953.00 KRW | -221.75% |
| 2016 | -607.00 KRW | -8.15% |
| 2015 | -561.25 KRW | 25.07% |
| 2014 | -749.00 KRW | 26.93% |
| 2013 | -1025.00 KRW | -35.22% |
| 2012 | -758.00 KRW | -55.65% |
| 2011 | -487.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 359.27 KRW | 119.09% |
| 2024 Q1 | 163.86 KRW | 89.83% |
| 2023 Q1 | -30.25 KRW | 94.6% |
| 2023 Q3 | -177.90 KRW | 40.31% |
| 2023 Q2 | -298.06 KRW | -885.32% |
| 2023 FY | - KRW | 76.42% |
| 2023 Q4 | 86.32 KRW | 148.52% |
| 2022 FY | - KRW | -315.02% |
| 2022 Q4 | -560.05 KRW | -193.13% |
| 2022 Q3 | -191.06 KRW | 67.06% |
| 2022 Q2 | -580.00 KRW | -28.89% |
| 2022 Q1 | -450.00 KRW | -174.83% |
| 2021 FY | - KRW | 124.02% |
| 2021 Q4 | 601.40 KRW | 206.38% |
| 2021 Q2 | -855.51 KRW | -151.94% |
| 2021 Q3 | -565.35 KRW | 33.92% |
| 2021 Q1 | 1647.00 KRW | 321.94% |
| 2020 FY | - KRW | 5.62% |
| 2020 Q4 | -742.08 KRW | 12.7% |
| 2020 Q2 | -913.00 KRW | 10.93% |
| 2020 Q1 | -1025.00 KRW | -25.54% |
| 2020 Q3 | -850.00 KRW | 6.9% |
| 2019 Q4 | -816.45 KRW | -5.62% |
| 2019 FY | - KRW | -64.62% |
| 2019 Q3 | -773.00 KRW | -17.84% |
| 2019 Q2 | -656.00 KRW | -159.15% |
| 2019 Q1 | 1109.00 KRW | 0.0% |
| 2018 FY | - KRW | -13.62% |
| 2017 FY | - KRW | -221.75% |
| 2016 FY | - KRW | -8.15% |
| 2015 FY | - KRW | 25.07% |
| 2014 FY | - KRW | 26.93% |
| 2013 FY | - KRW | -35.22% |
| 2012 FY | - KRW | -55.65% |
| 2011 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | 486.817% |
| Green Cross Holdings Corporation | -1210.00 KRW | 65.298% |
| Green Cross Holdings Corporation | -2333.42 KRW | 82.005% |
| Pharmicell Co., Ltd. | 60.00 KRW | 799.817% |
| Green Cross Corporation | -2333.42 KRW | 82.005% |
| GeneOne Life Science, Inc. | -1000.23 KRW | 58.021% |
| Celltrion, Inc. | 3759.00 KRW | 111.17% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 103.485% |
| SK bioscience Co.,Ltd. | 291.00 KRW | 244.292% |
| Prestige BioPharma Limited | -547.81 KRW | 23.351% |